NEUMOLOGÍA PEDIÁTRICA

Neumol Pediatr 2020; 15 (4): 429 - 483 C o n t e n i d o d i s p o n i b l e e n h t t p : / / www. n e umo l o g i a - p e d i a t r i c a . cl 481 Consenso chileno para la atención integral de niños y adultos con fibrosis quística 2014;6(Suppl 4). 100. Lord RW, Jones AM, Webb AK, Barry PJ. Pneumo- thorax in cystic fibrosis: beyond the guidelines. Paediatr Respir Rev. 2016;20:30–3. 101. Flume PA, Mogayzel PJ, Robinson KA, Rosenblatt RL, Quittell L, Marshall BC, et al. Cystic fibrosis pul- monary guidelines: Pulmonary complications: Hemop- tysis and pneumothorax. Am J Respir Crit Care Med. 2010;182(3):298–306. 102. de Vries JJV, Chang AB, Marchant JM. Comparison of bronchoscopy and bronchoalveolar lavage findings in three types of suppurative lung disease. Pediatr Pulmo- nol. 2018;53(4):467–74. 103. Paul L. Is bronchoscopy an obsolete tool in cystic fi- brosis? The role of bronchoscopy in cystic fibrosis and its clinical use. J Thorac Dis. 2017;9(Suppl 10):S1139–45. 104. Jain K, Wainwright C, Smyth AR. Bronchoscopy-gui- ded antimicrobial therapy for cystic fibrosis. Cochrane Database Syst Rev. 2018;2018(9). 105. Fayon M, Kent L, Bui S, Dupont L, Sermet I. Clini- metric properties of bronchoalveolar lavage inflammatory markers in cystic fibrosis. Eur Respir J. 2014;43(2):610– 26. 106. Newton TJ. Respiratory care of the hospitalized pa- tient with cystic fibrosis. Respir Care. 2009;54(6):769– 75. 107. Conway S, Balfour-Lynn IM, De Rijcke K, Drevinek P, Foweraker J, Havermans T, et al. European cystic fibrosis society standards of care: Framework for the cystic fibro- sis centre. J Cyst Fibros. 2014;13(S1). 108. Caceres Guido P, Perez M, Halac A, Ferrari M, Ibarra M, Licciardone N, et al. Population pharmacokinetics of amikacin in patients with pediatric cystic fibrosis. Pediatr Pulmonol. 2019;54(11):1801–10. 109. Pettit RS, Peters SJ, McDade EJ, Kreilein K, Patel R, Epps K, et al. Vancomycin dosing and monitoring in the treatment of cystic fibrosis: Results of a national practice survey. J Pediatr Pharmacol Ther. 2017;22(6):406–11. 110. Rogers D, Doull IJM. Physiological principles of airway clearance techniques used in the physiothe- rapy management of cystic fibrosis. Curr Paediatr. 2005;15(3):233–8. 111. Button BM, Wilson C, Dentice R, Cox NS, Middleton A, Tannenbaum E, et al. Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideli- ne. Respirology. 2016;21(4):656–67. 112. Nicolais CJ, Bernstein R, Saez-Flores E, McLean KA, Riekert KA, Quittner AL. Identifying Factors that Facili- tate Treatment Adherence in Cystic Fibrosis: Qualitative Analyses of Interviews with Parents and Adolescents. J Clin Psychol Med Settings. 2019;26(4):530–40. 113. Schneiderman JE, Wilkes DL, Atenafu EG, Nguyen T, Wells GD, Alarie N, et al. Longitudinal relationship be- tween physical activity and lung health in patients with cystic fibrosis. Eur Respir J. 2014;43(3):817–23. 114. Wilson LM, Morrison L, Robinson KA. Airway clea- rance techniques for cystic fibrosis: An overview of Co- chrane systematic reviews. Cochrane Database Syst Rev. 2019;1(1):CD011231. 115. Van Der Schans CP. Conventional chest physi- cal therapy for obstructive lung disease. Respir Care. 2007;52(9):1198–206. 116. Puppo H, Hidalgo G. Chest Physiotherapy. En: Ber- trand P, Sánchez I, editores. Pediatric Respiratory Disea- ses: A Comprehensive Textbook. Santiago, Chile: Sprin- ger Nature Switzerland AG 2020; 2020. 117. Muñoz G, De Gracia J, Buxó M, Alvarez A, Vendrell M. Long-term benefits of airway clearance in bronchiec- tasis: A randomised placebo-controlled trial. Eur Respir J. 2018;51(1). 118. Ward N, Stiller K, Holland AE. Exercise as a thera- peutic intervention for people with cystic fibrosis. Expert Rev Respir Med. 2019;13(5):449–58. 119. (No Title) [Internet]. [citado 19 de noviembre de 2020]. Disponible en: https://www.neumologia -pediatri- ca.cl/wp-content/uploads/2017/07/guias-rehabilitacion. pdf 120. Szeinberg A, Marcotte JE, Roizin H, Mindorff C, England S, Tabachnik E, et al. Normal values of maxi- mal inspiratory and expiratory pressures with a portable apparatus in children, adolescents, and young adults. Pediatr Pulmonol. 1987;3(4):255–8. 121. Gatica D, Puppo H, Villarroel G, Martín IS, Lagos R, Montecino JJ, et al. Valores de referencia del test de marcha de seis minutos en niños sanos. Rev Med Chil. 2012;140(8):1014–21. 122. Turck D, Braegger CP, Colombo C, Declercq D, Mor- ton A, Pancheva R, et al. ESPEN-ESPGHAN-ECFS guideli- nes on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr. 2016;35(3):557–77. 123. Somaraju URR, Solis-Moya A. Pancreatic enzyme replacement therapy for people with cystic fibrosis. Co- chrane Database Syst Rev. 2020;2020(8). 124. Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H. Evidence-Based Practice Recommenda- tions for Nutrition-Related Management of Children and Adults with Cystic Fibrosis and Pancreatic Insufficien- cy: Results of a Systematic Review. J Am Diet Assoc. 2008;108(5):832–9. 125. Schwarzenberg SJ, Hempstead SE, McDonald CM, Powers SW, Wooldridge J, Blair S, et al. Enteral tube fe- eding for individuals with cystic fibrosis: Cystic Fibrosis Foundation evidence-informed guidelines. J Cyst Fibros. 2016;15(6):724–35. 126. Barja Y. S, Rebollo G. MJ. Manejo nutricional en ni- ños y adolescentes con fibrosis quística. Rev Chil Pediatr. 2009;80(3):274–84. 127. Tabori H, Arnold C, Jaudszus A, Mentzel HJ, Renz DM, Reinsch S, et al. Abdominal symptoms in cystic fi- brosis and their relation to genotype, history, clinical and laboratory findings. PLoS One. 2017;12(5). 128. Assis DN, Freedman SD. Gastrointestinal Disorders in Cystic Fibrosis. Clin Chest Med. 2016;37(1):109–18. 129. Sankararaman S, Schindler T, Sferra TJ. Manage- ment of Exocrine Pancreatic Insufficiency in Children. Nutr Clin Pract. 2019;34(S1):S27–42. 130. Sakiani S, Kleiner DE, Heller T, Koh C. Hepa- tic Manifestations of Cystic Fibrosis. Clin Liver Dis.